The Value of HPA Axis Hormones as Biomarkers for Screening and Early Diagnosis of Postpartum Depression: Updated Information About Methodology
Authors:
Open Access
- 12 July 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 916611
Abstract
Because of the high prevalence of postpartum depression (PPD) and the suffering involved, early diagnosis is urgent; however, current screening tools and diagnosis are inadequate. In addition to conventional methods such as the Edinburgh Postnatal Depression Scale and clinical interviews, several hormones in the hypothalamic–pituitary–adrenal (HPA) axis, such as corticotrophin-releasing hormone, adrenocorticotropic hormone, and cortisol, have been considered because of their critical roles in stress regulation in the mothers. The study designs are complicated, however, and so the effectiveness of these hormones as biomarkers for PPD is still controversial. Such inconsistency may have resulted from the variation in methodology between studies. The methodology problems in the investigation of PPD and HPA axis hormones have not been reported extensively. We therefore sought to summarize the methodological problems of studies published in the past decade, including the strengths and weaknesses of the examinations and the technological difficulties involved. Our findings suggest that (a) suitable samples and appropriate detection methods would reduce heterogeneity among trials; (b) the cutoff value of the scale test should be carefully selected for determining the performance of biomarker tests; (c) evaluation methods and criteria should be chosen with consideration of the tools feasible for use in local hospitals and population; and (d) the cost of diagnosis should be reduced. We hope that these findings provide insight for future investigations of HPA axis hormones as biomarkers for screening and early diagnosis of PPD.Keywords
This publication has 98 references indexed in Scilit:
- Hair cortisol, stress exposure, and mental health in humans: A systematic reviewPsychoneuroendocrinology, 2013
- Predictors of postpartum depression in a sample of Egyptian womenNeuropsychiatric Disease and Treatment, 2012
- Elevated Corticotropin Releasing Hormone (CRH) during Pregnancy and Risk of Postpartum Depression (PPD)The Journal of Clinical Endocrinology & Metabolism, 2011
- Classification of mental health disorders in the perinatal period: future directions for DSM-V and ICD-11Archives of Women's Mental Health, 2010
- Seasonal variation in blood concentrations of interleukin-6, adrenocorticotrophic hormone, metabolites of catecholamine and cortisol in healthy volunteersInternational Journal of Biometeorology, 2009
- Bioassay Research Methodology: Measuring CRH in PregnancyBiological Research For Nursing, 2008
- Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: A prospective investigationAmerican Journal of Obstetrics and Gynecology, 2004
- Review of validation studies of the Edinburgh Postnatal Depression ScaleActa Psychiatrica Scandinavica, 2001
- Pulsatile fluctuations of plasma‐gonadotropin‐releasing hormone and corticotropin‐releasing factor levels in healthy pregnant womenActa Obstetricia et Gynecologica Scandinavica, 1994
- Detection of Postnatal DepressionThe British Journal of Psychiatry, 1987